Cargando…

1461. Non-Invasive Pneumococcal Pneumonia in the United States, 2013–2014

BACKGROUND: Surveillance for pneumococcal pneumonia (PP) is challenging due to limitations of available diagnostic tests. Previous studies estimated PP from all-cause pneumonia or invasive pneumonia (i.e., positive S. pneumoniae sterile site culture). In 2014, pneumococcal conjugate vaccine (PCV13)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Matanock, Almea, Gierke, Ryan, Shang, Nong, Watt, James, Alden, Nisha, Petit, Susan, Farley, Monica M, Harrison, Lee H, Schleiss, Katherine, Burzlaff, Kari, Thomas, Ann, Schaffner, William, Langley, Gayle E, Pilishvili, Tamara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2018
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6253068/ http://dx.doi.org/10.1093/ofid/ofy210.1291

Ejemplares similares

1474. Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Non-bacteremic Pneumococcal Pneumonia (NBPP) among Adults in the United States, 2013-2017
por: Gierke, Ryan, et al.
Publicado: (2020)

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices
por: Matanock, Almea, et al.
Publicado: (2019)

70. Changes in Invasive Pneumococcal Disease among Adults Living with HIV Following Introduction of 13-Valent Pneumococcal Conjugate Vaccine, 2008–2018
por: Matanock, Almea, et al.
Publicado: (2021)

Changes in invasive pneumococcal disease among adults living with HIV following introduction of 13-valent pneumococcal conjugate vaccine, 2008–2014
por: Kobayashi, Miwako, et al.
Publicado: (2017)

1470. Epidemiology of Invasive Pneumococcal Disease (IPD) Following 18 years of Pneumococcal Conjugate Vaccine (PCV) Use in the United States
por: Pilishvili, Tamara, et al.
Publicado: (2020)

180. Impact of Pneumococcal Conjugative Vaccine on Antibiotic Resistant Invasive Pneumococcal Disease in the United States
por: Bajema, Kristina, et al.
Publicado: (2020)

Direct and Indirect Impact of 13-valent Pneumococcal Conjugate Vaccine (PCV13) on Invasive Pneumococcal Disease (IPD) Among Children and Adults in the U.S.
por: Pilishvili, Tamara, et al.
Publicado: (2017)

596 Potential public health impact of 13-valent pneumococcal conjugate vaccine use among US adults 65 years of age or older
por: Pilishvili, Tamara, et al.
Publicado: (2014)

1718. Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease among children in the United States between 2010 and 2019: an indirect cohort study
por: Andrejko, Kristin, et al.
Publicado: (2023)

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
por: Bennett, Nancy M., et al.
Publicado: (2013)

1436. Risk Factors for Invasive Pneumococcal Disease in Adults ≥65 Years Old Following Pneumococcal Conjugate Vaccine Recommendation
por: Almendares, Olivia M, et al.
Publicado: (2018)

Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
por: Tomczyk, Sara, et al.
Publicado: (2014)

2718. Effectiveness of 13-Valent Pneumococcal Conjugate Vaccine in US Adults Hospitalized with Pneumonia, 2014–2017
por: Lessa, Fernanda C, et al.
Publicado: (2019)

1461. Antimicrobial Susceptibility Patterns of Common Complicated Urinary Tract Infection Pathogens in US Hospitals, 2013–2018
por: Zilberberg, Marya, et al.
Publicado: (2019)

Frequency and signature of somatic variants in 1461 human brain exomes
por: Wei, Wei, et al.
Publicado: (2018)

151. Evaluation of Pneumococcal Vaccine Effectiveness Against Invasive Pneumococcal Disease Among US Medicare Beneficiaries ≥65 Years Old
por: Pilishvili, Tamara, et al.
Publicado: (2018)

13. The Efficacy and Effectiveness of Pneumococcal Vaccines against Pneumococcal Pneumonia among Adults: A Systematic Review and Meta-Analysis
por: Childs, Lana, et al.
Publicado: (2021)

The chemistry and biology of KP-1461, a selective nucleoside mutagen for HIV therapy
por: Harris, Kevin, et al.
Publicado: (2006)

PO-1461 Impact of the COVID-19 pandemic on Radiation Oncology Departments in Brazil
por: Yoshinari Jr, G.H., et al.
Publicado: (2021)

1461. The Impact of Universal Varicella Vaccination on Herpes Zoster Incidence in the United States
por: Leung, Jessica W, et al.
Publicado: (2022)

Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022
por: Kobayashi, Miwako, et al.
Publicado: (2022)

Genome-wide association analyses of invasive pneumococcal isolates identify a missense bacterial mutation associated with meningitis
por: Li, Yuan, et al.
Publicado: (2019)

Mutation of HIV-1 Genomes in a Clinical Population Treated with the Mutagenic Nucleoside KP1461
por: Mullins, James I., et al.
Publicado: (2011)

Retinal oxygen saturation in 1461 healthy children aged 7–19 and its associated factors
por: Liu, Xiaoxiao, et al.
Publicado: (2019)

Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023
por: Kobayashi, Miwako, et al.
Publicado: (2023)

Pneumococcal Vaccination Among Medicare Beneficiaries Occurring After the Advisory Committee on Immunization Practices Recommendation for Routine Use Of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine for Adults Aged ≥65 Years
por: Black, Carla L., et al.
Publicado: (2017)

1461. Impact of the Ampicillin/Sulbactam Shortage on Antibiotic Prescribing and Clinical Outcomes for Adult Inpatients with Aspiration Pneumonia
por: Staicu, Mary L, et al.
Publicado: (2020)

Modified Activated Carbon: A Supporting Material for Improving Clostridium beijerinckii TISTR1461 Immobilized Fermentation
por: Chinwatpaiboon, Piyawat, et al.
Publicado: (2023)

647 Impact of 13-valent Pneumococcal Conjugate Vaccine on Invasive Pneumococcal Disease in the United States
por: Kim, Lindsay, et al.
Publicado: (2014)

841 Estimation of Undiagnosed Neuroinfectious Deaths with the Epidemiologic Pattern of Primary Amebic Meningoencephalitis Caused by Naegleria fowleri
por: Matanock, Almea, et al.
Publicado: (2014)

Pneumococcal Conjugate Vaccine Impact on Meningitis and Pneumonia Among Children Aged <5 Years—Zimbabwe, 2010–2016
por: Dondo, Vongai, et al.
Publicado: (2019)

Systematic Review and Meta-Analysis of the Efficacy and Effectiveness of Pneumococcal Vaccines in Adults
por: Farrar, Jennifer L., et al.
Publicado: (2023)

Coronavirus Disease 2019 in Children — United States, February 12–April 2, 2020
por: Bialek, Stephanie, et al.
Publicado: (2020)

Estimation of Undiagnosed Naegleria fowleri Primary Amebic Meningoencephalitis, United States
por: Matanock, Almea, et al.
Publicado: (2018)

Cluster of Ebola Cases Among Liberian and U.S. Health Care Workers in an Ebola Treatment Unit and Adjacent Hospital — Liberia, 2014
por: Forrester, Joseph D., et al.
Publicado: (2014)

Pneumococcal Disease Outbreak at a State Prison, Alabama, USA, September 1–October 10, 2018
por: Sanchez, Guillermo V., et al.
Publicado: (2021)

20. Cost-Effectiveness of Implementing 13-Valent Pneumococcal Conjugate Vaccine (Pcv13) for Adults Aged ≥19 Years with Underlying Conditions
por: Kobayashi, Miwako, et al.
Publicado: (2020)

Hospitalizations for COVID-19 Among American Indian and Alaska Native Adults (≥ 18 Years Old) — New Mexico, March–September 2020
por: Hicks, Joseph T., et al.
Publicado: (2022)

Mutations based on viral decay acceleration in the HIV-1 genomes of a clinical population treated with the mutagenic nucleoside KP1461
por: Mullins, James I, et al.
Publicado: (2011)

Differences in Characteristics and Clinical Outcomes Among Hispanic/Latino Men and Women Receiving HIV Medical Care — United States, 2013–2014
por: Luna-Gierke, Ruth E., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lofun1cgbn3vjb22ohnndi5v0a